Home - Biotoscana Institucional

Knight Therapeutics Inc. is a pan-American (ex-US) specialty pharmaceutical company focused on acquiring, in licensing, out-licensing, marketing, and commercializing innovative prescription pharmaceuticals in Canada and Latin America. Knight owns Biotoscana Investments S.A., a pan-Latin American specialty pharmaceutical company.

<h2 style=

Knight Therapeutics Inc.’s shares trade on TSX under the symbol GUD. Headquartered in Montreal, Knight has over 700 employees globally.

Knight Therapeutics Inc.’s shares trade on TSX under the symbol GUD. Headquartered in Montreal, Knight has over 700 employees globally.

State-of-the-art infrastructure, including regionally capable sales, marketing, R&D, regulatory, access and manufacturing

<span>State-of-the-art infrastructure, including regionally capable sales, marketing, R&D, regulatory, access and manufacturing</span>